Unrelated donor vs HLA-haploidentical α/β T-cell– and B-cell–depleted HSCT in children with acute leukemia

The potential role of γδ T cells after allogeneic HCT for leukemia

(2018) Rupert Handgretinger et al.   BLOOD

Haploidentical hematopoietic transplantation for the cure of leukemia: from its biology to clinical translation

(2016) A. Mancusi et al.   BLOOD

Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation

(2015) S. G. Holtan et al.   BLOOD

Improved immune recovery after transplantation of TCRαβ/CD19-depleted allografts from haploidentical donors in pediatric patients

(2015) P Lang et al.   BONE MARROW TRANSPLANTATION

Monitoring of Minimal Residual Disease After Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia Allows for the Identification of Impending Relapse: Results of the ALL-BFM-SCT 2003 Trial

(2015) Peter Bader et al.   JOURNAL OF CLINICAL ONCOLOGY

Haplo is the new black

(2014) M. A. Pulsipher   BLOOD

KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL

(2014) L. Oevermann et al.   BLOOD

HLA-haploidentical stem cell transplantation after removal of   + T and B cells in children with nonmalignant disorders

(2014) A. Bertaina et al.   BLOOD

Transplantation of CD3/CD19 depleted allografts from haploidentical family donors in paediatric leukaemia

(2014) Peter Lang et al.   BRITISH JOURNAL OF HAEMATOLOGY

HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the U.S. Registry

(2014) Loren Gragert et al.   NEW ENGLAND JOURNAL OF MEDICINE

Natural killer cells in the treatment of high-risk acute leukaemia

(2014) Franco Locatelli et al.   SEMINARS IN IMMUNOLOGY

Negative depletion of α/β+ T cells and of CD19+ B lymphocytes: A novel frontier to optimize the effect of innate immunity in HLA-mismatched hematopoietic stem cell transplantation

(2013) Franco Locatelli et al.   IMMUNOLOGY LETTERS

High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease

(2010) L. Luznik et al.   BLOOD

Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia

(2010) S. Cooley et al.   BLOOD

Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation

(2010) L. Moretta et al.   BLOOD

High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation

(2010) Leo Luznik et al.   IMMUNOLOGIC RESEARCH

Rituximab reduces the incidence of acute graft-versus-host disease

(2009) M. Christopeit et al.   BLOOD

Improving cord blood transplantation in children

(2009) Franco Locatelli   BRITISH JOURNAL OF HAEMATOLOGY

Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity

(2008) D. Pende et al.   BLOOD

Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: An update

(2007) Wolfgang A. Bethge et al.   BLOOD CELLS MOLECULES AND DISEASES